Latest filing published 02 Nov 2026 for Oruka Therapeutics, Inc., €2.2M.
Insider track record
No signal scores available.
Lawrence Klein: trading record in brief
Lawrence Klein discloses dealings in Oruka Therapeutics, Inc. to SEC (Form 4). We count 2 filings; the first trade dates from 1 October 2026 and the latest from 2 November 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 2 November 2026 came the latest disclosure, a transaction for €2.2M in Oruka Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Lawrence Klein
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,000 shares@ US$96.87CommonSEC144:0001950047-26-010585
- 25,000 shares@ US$83.290.038% mcap100.0% of flowCommonSEC144:0001950047-26-009940
2 of 2 declarations
